We use cookies to ensure that we give you the best experience on our website Learn more

Jun 23, 2018

MASCC/ISOO Annual Meeting on Supportive Care in Cancer

09 / A STATE-WIDE CANCER CLINICAL TRIALS NETWORK TO INCREASE THE REACH AND IMPACT OF CANCER CARE DELIVERY RESEARCH AND OPTIMISE CARE FOR PEOPLE AFFECTED BY CANCER

;

Sharplin, G.;

Joshi, R.;

Brown, M.P.;

Karapetis, C.;

Price, T.;

Singhal, N.;

Osborn, M.;

Poprawski, D.;

Brown, A.;

Marker, J.;

Christensen, C.;

Eckert, M.;

Olver, I.

cancer care delivery research

clinical trials

health services research

consumer-centred care research

supportive care research

Abstract

Abstract

thumbnail

Keywords

cancer care delivery research

clinical trials

health services research

consumer-centred care research

supportive care research

Abstract

Introduction: Cancer clinical trials networks (CTN) predominantly support pharmaceutical, surgical or device trials targeting cures or reducing disease impact. Cancer care delivery research (CCDR) examines how clinical, organisational, financial, technological, system, and human factors influence care quality, cost, access and equity and the health and well-being of consumers. CTNs have the capacity to link disparate trial sites to support large CCDR projects. Objective: To undertake large CCDR projects to optimise supportive care, treatment and healthcare outcomes for consumers using a state-wide CTN as the research platform. Methods: A CTN formally linking all CT units across diverse settings in South Australia (the SACTN) will be a platform for improved CCDR. Researchers will develop, refine, and implement co-designed CCDR projects involving multiple stakeholders in its conduct; uses standardised healthcare quality measures; examines causal pathways and critical components of practice change. Results: This novel program will increase the number, size, and scope of CCDR projects and support recruitment of consumer participants. CCDR outcomes will inform cancer service delivery at networked sites underpinning optimisation of healthcare delivery, consumer-centred care and clinical outcomes; key objectives of the SACTN strategy. Conclusion: CDR that leverages the SACTN will complement clinical trials by focusing on other components of cancer care across a diverse population to optimise the benefits of clinical intervention. The program will enhance supportive care, treatment and clinical research, and aligns to and supports the implementation of national and SA strategic initiatives like national cancer control indicators, optimal care pathways, the SA Cancer Plan and the SA Cancer Research Strategy.

Discover over 20,000 new abstracts, posters and presentations from leading academic conferences every month. Stay on top of the latest findings, methodologies and discussions happening in your research field around the world.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.